Do allergies to contrast media last?
Part of Immune system & allergy clinical trials.
This study looks at whether an allergy to contrast media (the dye used in scans) lasts over time. If you've had a reaction before, participating may help doctors understand if the allergy goes away or stays.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a documented allergy to contrast media (the substance used to make scans clearer).
- You cannot be taking antihistamines for an allergy at the time of the study.
- You cannot have active eczema or uncontrolled asthma.
- If you are a woman, you cannot be pregnant, breastfeeding, or have recently given birth.
- You need health insurance coverage and must give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a new blood test can measure allergy-related immune signals (IgE) in people with known or suspected allergies. If it works well, it could help doctors diagnose and track IgE allergies more easily.
This study tests whether a one-hour premedication can prevent allergic reactions to CT contrast dye. If you have a known allergy to this dye and need an emergency CT, you might be eligible.
This study is building a tool to predict which patients might have leakage of the contrast dye used in scans. It could help prevent complications during imaging procedures.
This study looks at how contrast dye used in imaging tests (like CT scans) can sometimes affect the kidneys. Researchers want to track patients at Sohag University Hospitals to better understand and prevent kidney injury after receiving contrast.
This trial tests a new medication called CZ10 to see if it is safe in healthy people. It is a first-in-human study, so it will help determine if the drug is safe for future patients.
This study looks at different kinds of allergy-related antibodies in people who had an allergic reaction during surgery. The goal is to better understand what immune signals are involved so future allergy prevention and care can improve.
Hear when a new Contrast Media Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.